Teva Pharmaceuticals Reports Positive Real-World Outcomes for UZEDY® (risperidone) in Schizophrenia Treatment Compared to Second-Generation Oral Antipsychotics
Teva announces positive real-world outcomes for UZEDY® and TEV-‘749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits.